A global partnership, coordinated by the Karolinska Institutet and in which IDIBAPS researchers participate, has received 15 million euros from the European Commission framework program Horizon2020 to find new and improved treatments for Multiple Sclerosis (MS). This project, named MultipleMS, involves universities and companies from 12 European countries and the USA, which will join efforts to adapt the development and application of therapies to each MS patient.
MISSION EUPON inspires European multidisciplinary collaborations to further the knowledge in ophthalmological and neurological optic nerve pathologies. VISION To be a European reference and lead international efforts in diagnostic, therapeutic and research strategies involving optic nerve. TARGET AUDIENCE Opthalmologist, Neurologist, Engineers working in Biomedicine, Optometrists, Nurses
By Dr. Xavier Salas Puig; director de la Unidad de Epilepsia y profesor Asociado de Neurología en Hospital Universitari Vall d'Hebron. Universitat Autónoma de Barcelona
Servei Neurologia- Hospital Clinic